P421 Real-world effectiveness and safety of vedolizumab induction therapy for Crohn’s disease in Poland – a prospective, observational POLONEZ II study considering patients reporte... by Liebert, A, Kłopocka, M, Cichoż-Lach, H, Michalak, A, Talar-Wojnarowska, R, Domżał-Magrowska, D, Filipiuk, A, Krogulecki, M, Kopertowska-Majchrzak, M, Eder, P, Stawczyk-Eder, K, Waszak, K, Zagórowicz, E, Wojciechowski, K, Drygała, S

Get full text

P363 The minimal invasive surgery in combination with negative pressure wound therapy for perianal fistulas in Crohn’s colitis lead to the fast introduction of the biological treat... by Banasiewicz, T, Paszkowski, J, Hermann, J, Cwalinski, J, Eder, P, Stawczyk-Eder, K, Waszak, K, Dobrowolska, A

Get full text

P824 Molecular predictors of anti-TNF treatment response in patients with Crohn’s disease by WALCZAK, M, Lykowska-Szuber, L, Plucinska, M, Michalak, M, Krela-Kazmierczak, I, Zakerska-Banaszak, O, Stawczyk-Eder, K, Eder, P, Dobrowolska, A, Slomski, R, Skrzypczak-Zielinska, M

Get full text

P076 Epithelial apoptotic loss is enhanced even in tissue from uninflamed mucosa in patients with Crohn's disease by Eder, P., Lykowska-Szuber, L., Krela-Kazmierczak, I., Stawczyk-Eder, K., Iwanik, K., Zabel, M., Linke, K.

Get full text